Login
Home
Charts
Search
Watchlist
Products

Sadhana Nitro Chem Ltd

SADHNANIQ·NSE
2.75-3.51%Wed, 23 Sept '26 15:55

Sadhana Nitro Chem Ltd

SADHNANIQ
NSE
2.75
-3.51%
|Wed, 23 Sept '26 15:55
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
849Cr
Close
Close Price
2.80
Industry
Industry
Dyes & Pigments
PE
Price To Earnings
PS
Price To Sales
17.40
Revenue
Revenue
49Cr
Rev Gr TTM
Revenue Growth TTM
-69.03%
PAT Gr TTM
PAT Growth TTM
-1,860.58%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4244653643374928310927
Growth YoY
Revenue Growth YoY%
15.041.334.0-8.42.1-15.8-23.4-22.2-93.7-73.7-81.6-3.1
Expenses
ExpensesCr
293355263526362620253225
Operating Profit
Operating ProfitCr
1311910811132-17-15-232
OPM
OPM%
29.825.914.426.619.330.326.76.9-628.9-155.6-250.58.5
Other Income
Other IncomeCr
012010040134
Interest Expense
Interest ExpenseCr
4444454457113
Depreciation
DepreciationCr
443443454443
PBT
PBTCr
4442145-2-26-25-340
Tax
TaxCr
2341111000-10
PAT
PATCr
3111034-2-26-25-34-1
Growth YoY
PAT Growth YoY%
794.624.0-70.5933.3-89.9177.4688.5-441.9-9,926.9-1,074.4-920.074.1
NPM
NPM%
6.12.10.81.70.67.08.3-7.5-946.3-257.6-369.1-2.0
EPS
EPS
0.00.00.00.00.00.00.00.0-0.2-0.2-0.10.0
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
4244653643374928310927
Growth YoY
Revenue Growth YoY%
15.041.334.0-8.42.1-15.8-23.4-22.2-93.7-73.7-81.6-3.1
Expenses
ExpensesCr
293355263526362620253225
Operating Profit
Operating ProfitCr
1311910811132-17-15-232
OPM
OPM%
29.825.914.426.619.330.326.76.9-628.9-155.6-250.58.5
Other Income
Other IncomeCr
012010040134
Interest Expense
Interest ExpenseCr
4444454457113
Depreciation
DepreciationCr
443443454443
PBT
PBTCr
4442145-2-26-25-340
Tax
TaxCr
2341111000-10
PAT
PATCr
3111034-2-26-25-34-1
Growth YoY
PAT Growth YoY%
794.624.0-70.5933.3-89.9177.4688.5-441.9-9,926.9-1,074.4-920.074.1
NPM
NPM%
6.12.10.81.70.67.08.3-7.5-946.3-257.6-369.1-2.0
EPS
EPS
0.00.00.00.00.00.00.00.0-0.2-0.2-0.10.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
36551142671061031321431901665049
Growth
Revenue Growth%
-25.654.0106.6134.3-60.3-2.827.88.832.6-12.9-70.0-69.0
Expenses
ExpensesCr
3447791477780117122149123103101
Operating Profit
Operating ProfitCr
2835121292315214142-53-53
OPM
OPM%
5.415.030.645.127.422.711.114.821.625.6-106.8-108.0
Other Income
Other IncomeCr
000125524298
Interest Expense
Interest ExpenseCr
565123351017182626
Depreciation
DepreciationCr
2223666815151615
PBT
PBTCr
-51281072219961312-87-85
Tax
TaxCr
00-331833294-10
PAT
PATCr
-51317615166348-86-85
Growth
PAT Growth%
-224.8110.36,019.5143.9-80.78.7-60.9-48.928.485.2-1,243.5-1,860.6
NPM
NPM%
-13.80.927.328.413.815.44.72.22.14.6-174.0-173.9
EPS
EPS
0.00.00.30.70.00.10.10.00.00.1-0.3-0.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
36551142671061031321431901665049
Growth
Revenue Growth%
-25.654.0106.6134.3-60.3-2.827.88.832.6-12.9-70.0-69.0
Expenses
ExpensesCr
3447791477780117122149123103101
Operating Profit
Operating ProfitCr
2835121292315214142-53-53
OPM
OPM%
5.415.030.645.127.422.711.114.821.625.6-106.8-108.0
Other Income
Other IncomeCr
000125524298
Interest Expense
Interest ExpenseCr
565123351017182626
Depreciation
DepreciationCr
2223666815151615
PBT
PBTCr
-51281072219961312-87-85
Tax
TaxCr
00-331833294-10
PAT
PATCr
-51317615166348-86-85
Growth
PAT Growth%
-224.8110.36,019.5143.9-80.78.7-60.9-48.928.485.2-1,243.5-1,860.6
NPM
NPM%
-13.80.927.328.413.815.44.72.22.14.6-174.0-173.9
EPS
EPS
0.00.00.30.70.00.10.10.00.00.1-0.3-0.5

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
999991420202533296
Reserves
ReservesCr
-1213796107116116206202248158
Current Liabilities
Current LiabilitiesCr
5952846486138178168158198147
Non Current Liabilities
Non Current LiabilitiesCr
220971436487214715857
Total Liabilities
Total LiabilitiesCr
6883139177216304386466532637658
Current Assets
Current AssetsCr
29345996112183219264265275265
Non Current Assets
Non Current AssetsCr
39498181104122167202267362393
Total Assets
Total AssetsCr
6883139177216304386466532637658
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
999991420202533296
Reserves
ReservesCr
-1213796107116116206202248158
Current Liabilities
Current LiabilitiesCr
5952846486138178168158198147
Non Current Liabilities
Non Current LiabilitiesCr
220971436487214715857
Total Liabilities
Total LiabilitiesCr
6883139177216304386466532637658
Current Assets
Current AssetsCr
29345996112183219264265275265
Non Current Assets
Non Current AssetsCr
39498181104122167202267362393
Total Assets
Total AssetsCr
6883139177216304386466532637658

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-193553-171-5-38-348-29
Investing Cash Flow
Investing Cash FlowCr
0-1-6-25-22-23-39-53-65-89-46
Financing Cash Flow
Financing Cash FlowCr
2-25-13-2330304672422593
Net Cash Flow
Net Cash FlowCr
1-17165-972-19-26-1618
Free Cash Flow
Free Cash FlowCr
-193553-17-7-43-80-69-46-93
CFO To PAT
CFO To PAT%
18.61,782.6112.569.5-114.24.2-75.5-1,189.8-66.7633.333.1
CFO To EBITDA
CFO To EBITDA%
-47.6109.7100.543.8-57.72.8-32.2-178.2-6.6113.153.9
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-193553-171-5-38-348-29
Investing Cash Flow
Investing Cash FlowCr
0-1-6-25-22-23-39-53-65-89-46
Financing Cash Flow
Financing Cash FlowCr
2-25-13-2330304672422593
Net Cash Flow
Net Cash FlowCr
1-17165-972-19-26-1618
Free Cash Flow
Free Cash FlowCr
-193553-17-7-43-80-69-46-93
CFO To PAT
CFO To PAT%
18.61,782.6112.569.5-114.24.2-75.5-1,189.8-66.7633.333.1
CFO To EBITDA
CFO To EBITDA%
-47.6109.7100.543.8-57.72.8-32.2-178.2-6.6113.153.9

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16392046182093582,5802,3141,544557409849
Price To Earnings
Price To Earnings
76.56.58.271.522.5412.2715.6367.673.5
Price To Sales
Price To Sales
0.40.71.82.32.03.519.616.18.13.48.217.4
Price To Book
Price To Book
-6.73.74.45.99.03.020.410.77.12.00.91.8
EV To EBITDA
EV To EBITDA
25.28.96.05.18.818.4183.9115.243.118.8-9.5-18.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
47.436.247.962.555.051.233.241.043.552.1-23.8-23.8
OPM
OPM%
5.415.030.645.127.422.711.114.821.625.6-106.8-108.0
NPM
NPM%
-13.80.927.328.413.815.44.72.22.14.6-174.0-173.9
ROCE
ROCE%
0.514.854.6105.615.510.45.44.26.65.5-10.7-10.7
ROE
ROE%
207.74.967.872.112.612.34.61.41.82.7-19.0-19.0
ROA
ROA%
-7.20.622.342.96.85.21.60.70.81.2-13.1-13.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
16392046182093582,5802,3141,544557409849
Price To Earnings
Price To Earnings
76.56.58.271.522.5412.2715.6367.673.5
Price To Sales
Price To Sales
0.40.71.82.32.03.519.616.18.13.48.217.4
Price To Book
Price To Book
-6.73.74.45.99.03.020.410.77.12.00.91.8
EV To EBITDA
EV To EBITDA
25.28.96.05.18.818.4183.9115.243.118.8-9.5-18.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
47.436.247.962.555.051.233.241.043.552.1-23.8-23.8
OPM
OPM%
5.415.030.645.127.422.711.114.821.625.6-106.8-108.0
NPM
NPM%
-13.80.927.328.413.815.44.72.22.14.6-174.0-173.9
ROCE
ROCE%
0.514.854.6105.615.510.45.44.26.65.5-10.7-10.7
ROE
ROE%
207.74.967.872.112.612.34.61.41.82.7-19.0-19.0
ROA
ROA%
-7.20.622.342.96.85.21.60.70.81.2-13.1-13.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Sadhana Nitro Chem Ltd is fundamentally a chemistry company that turns a single starting material-benzene-into a widening family of high-purity molecules for the world’s biggest brands, from L’Oréal to Bayer. It began in 1973 as a small Indian manufacturer and, over five decades, evolved into the largest maker of Meta Amino Phenol (MAP) globally and the only Indian producer of the thermal-paper chemical ODB2, a journey now being repeated with a government-backed push to make the active ingredient in paracetamol using a cleaner, patent-pending process. The recurring approach that explains everything else is vertical integration married to green chemistry: the company keeps moving one step further back to control its own raw materials and one step further forward into higher-value derivatives, while designing processes that turn waste into saleable co-products instead of effluent. # Business segments Three engines built on the same benzene backbone-a legacy specialty-chemicals franchise that dominates its niche, a scaled-up colourformer platform that competes on cost, and a pharmaceutical-intermediates bet under construction-each funded by the cash flows of the one before. ## 1. Legacy aromatic intermediates: the world’s MAP leader and a portfolio of niche molecules **SNCL is the largest manufacturer of Meta Amino Phenol (MAP) globally and the only supplier whose MAP is qualified for all twelve of its end applications, from L’Oréal’s cosmetics to aerospace resins.** - **Backward integration from benzene** - the company starts with benzene and converts it all the way to MAP using a no-solvent process that distills crude MAP directly into white flakes of 99.95% purity, compared to the off-white granules and lower purity that Chinese competitors achieve. - **A portfolio of nitro-compound cousins** - the same manufacturing logic extends to a range of other intermediates, including Nitrobenzene (12,000 TPA capacity), Aniline Oil (1,200 TPA), and aerospace-grade molecules like 3,3 Dinitro Diphenyl Sulphone (300 TPA), each serving a distinct industrial niche. - **Legacy products find new life** - products like MAP are being developed for next-generation applications in advanced materials sciences through close collaboration with customers, so the portfolio does not depend on static demand. ## 2. ODB2 and thermal-paper colourformers: the cost leader built on the MAP backbone **SNCL is the only manufacturer of ODB2 in India and, after a fourfold capacity expansion, claims to be the biggest and lowest-cost producer of this thermal-paper chemical in the world.** - **Backward integrated from benzene to finished colourformer** - ODB2 is made by taking MAP, which the company already produces, and converting it further to Keto Acid and then to the final colourformer molecule, so the entire chain sits under one roof. - **Scale as the answer to Chinese pricing** - the plant was expanded from 550 tonnes per year to 2,200 tonnes per year, a deliberate move to compensate for competitive pressure from China by winning on volume what cannot be won on price alone. - **One of only two outside China** - since resuming colourformer manufacturing, SNCL has emerged as one of just two companies outside China offering the product, giving global thermal-paper coaters a rare alternative supplier. - **Full integration is the endgame** - from 2024, the company began in-house manufacturing of a key raw material previously imported from China; once complete, SNCL will be the only ODB2 manufacturer globally with a fully consolidated plant backward integrated from Nitrobenzene. ## 3. Para-Amino Phenol (PAP): the paracetamol supply chain, built on a cleaner chemistry **SNCL is scaling a patent-pending process to make Para-Amino Phenol-the active ingredient in paracetamol-from Nitrobenzene instead of the polluting Chinese route, backed by a government PLI grant to reach 36,000 tonnes per year.** - **A fundamentally different chemistry** - the company’s process uses a single-stage hydrogen reduction of Nitrobenzene, whereas Chinese and other Indian manufacturers use the PNCB route; SNCL’s route is effluent-free, produces a pure white product, and generates four saleable co-products (Aniline, Ammonium Sulphate, Ortho Amino Phenol, and 4,4 Oxy Dianiline) instead of toxic waste. - **Only the second plant of its kind in the world** - the facility has received consent to establish from the Maharashtra Pollution Control Board, and the process has been certified as 100% effluent-free and zero-discharge by the Institute of Chemical Technology. - **A supply gap the world needs filled** - global PAP demand is 160,000 tonnes per year and growing, but Chinese supply has shrunk from 150,000 to 80,000-100,000 tonnes per year due to permanent shutdowns over effluent issues, while India needs 60,000 tonnes per year and can currently import only 15,000. - **Scaling from pilot to full production** - the current run rate is about 3,000 tonnes per year against a listed capacity of 6,000 tonnes per year, with the PLI scheme targeting 36,000 tonnes per year, and the plant has now transitioned to a fully continuous production process to get there. # Green chemistry and energy transition **The company is wiring its entire manufacturing backbone to run on captive green hydrogen and solar power, while redesigning processes so that waste becomes a product.** - **Green hydrogen from its own renewable plant** - SNCL is building a green hydrogen facility powered by a 15-20 MW solar plant and wind farm for captive use, transitioning its reduction technologies from conventional hydrogen to green hydrogen, which is expected to cut costs and give it control over a critical input. - **Zero effluent is the internal mandate** - the company has set a target of June 2026 for all products, including legacy ones, to achieve zero effluent discharge, and its R&D lab works on processes that are either effluent-free or convert effluent into sellable by-products. - **Waste already has a buyer** - solid waste streams like Gypsum go to cement and fertiliser industries, Sodium and Potassium Sulphite to paper and leather, and Iron Sludge to steel and cement, so what leaves the plant is a raw material for someone else. # Group structure and partners **A single integrated site in Roha, a newly absorbed neighbouring plant, and a promoter family that recently restructured its holding for tax efficiency.** - **One site, now with a neighbour** - the company operates from a 22-acre facility in Roha, Maharashtra, and in January 2025 took possession of Calchem Industries, a 14.5-acre plant just 250 metres away, acquired through an NCLT resolution plan to add approximately 78,000 tonnes per year of installed capacity for forward integration. - **Promoter holding restructured, not reduced** - in late 2025, the promoter group holding company transferred its entire 26.65% stake equally to the Executive Chairman and Managing Director as individuals via an off-market transaction, keeping aggregate promoter holding unchanged. - **A long-term contract with a Japanese multinational** - the company secured a two-year supply contract with an undisclosed Japanese customer for a specialty chemical, with a firm committed value of approximately Rs. 108 crores, taking the confirmed order book above Rs. 200 crores.

Documents — Sadhana Nitro Chem Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/t6j67lu15ykoihzk0k6u0jga.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7gziavhj8zlgp6eun3dghpy4.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/5yzf1gcdhjuzo06i48ma9amo.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/mc0z1bzknppu5ent04gyesql.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/4khho44sqnbit3ucylshllvp.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/l3ox3eb3yahh5rpsnlyhtgb6.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/hra0kdqob9s7p818rnygg0l2.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/65wg3cy3y3gkoh7omj9qvgyp.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/w0f2qgqg6hpelit9qllhxblx.pdf
  • Q3 FY2024 Investor Presentation (Dec 2023, PDF): https://www.stockscans.in/document/zc8c29okbhyqj8pypfkk1oe6.pdf
  • Q2 FY2024 Investor Presentation (Sep 2023, PDF): https://www.stockscans.in/document/ebgo8pz0ujid4ndkmgg37w4n.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/v9syei3byszqo65pfcvqb8mz.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/r5bwzxyh4hszdohhcv0y5mts.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/vo49215t8p0iv63wuh94a2i4.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/j3z4zwztrp0l6fzp1wzxwx5e.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/n2pgcfw1syr0wrx0cu4owheu.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/8uijo3rruxbpyrjhnkllnl9x.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/l0vx5fkvjoeatxkoau0x4yb7.pdf